出版物 打印 Shah MV, Hung K, Baranwal A, Wechalekar G, Al-Kali A, Toop CR, Greipp P, Kutyna MM, Matin A, Ladon D, Saliba A, Chen D, Begna K, Brown A, Rud D, Litzow MR, Hogan WJ, Bardy P, Badar T, Kumar S, Yeung DT, Patnaik MM, Foran JM, He R, Gangat N, Hefazi M, Scott HS, Arana Yi CY, Alkhateeb H, Mangaonkar AA, Thomas D, Hahn CN, Orazi A, Arber DA, Kok CH, Tefferi A, Hiwase D. Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort. Blood Cancer J. 2025 May 7; 15 (1):88 Epub 2025 May 07 View PubMed Acosta-Medina AA, Sridharan M, Go RS, Moyer AM, Leung N, Willrich MAV, Wolf R, Kassis R, Manasrah A, Kohorst MA, Durani U, Matin A, Hefazi M, Kenderian SJ, Mangaonkar AA, Shah MV, Litzow MR, Hogan WJ, Dingli D, Alkhateeb HB. Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk Criteria. Am J Hematol. 2025 May; 100 (5):830-839 Epub 2025 Mar 06 View PubMed Graham C, Baranwal A, Kietselaer B, Ayoub C, Larsen C, Langer KJ, Kharfan-Dabaja MA, Ayala E, Foran J, Murthy H, Roy V, Iqbal M, Palmer J, Sproat LZ, Chhabra S, Khera N, Hilal T, Durani U, Matin A, Torghabeh MH, Mangaonkar A, Shah MV, Litzow MR, Hogan WJ, Dingli D, Alkhateeb HB. Coronary Artery Calcification As a Predictor of Survival in Patients Receiving Post-transplant Cyclophosphamide For GVHD Prophylaxis. Transplant Cell Ther. 2025 Apr 24 [Epub ahead of print] View PubMed Gangat N, Elbeih A, Ghosoun N, McCullough K, Aperna F, Johnson IM, Abdelmagid M, Al-Kali A, Alkhateeb HB, Begna KH, Elliott M, Mangaonkar A, Matin A, Saliba AN, Hefazi Torghabeh M, Litzow MR, Hogan W, Shah M, Patnaik MM, Pardanani A, Badar T, Murthy H, Foran J, Palmer J, Sproat L, Khera N, Arana Yi C, Yates S, Sneider A, Dworkin E, Patel AA, Bazinet A, Senapati J, Bataller A, DiNardo C, Kadia T, Tefferi A. Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent. Am J Hematol. 2025 Feb; 100 (2):260-271 Epub 2024 Dec 13 View PubMed Matin A, Smith BH, Mangaonkar A, Duffy DJ, Wolf R, Alkhateeb H, Shah MV, Hogan WJ, Litzow MR. Pericardial Effusion as a Purported Manifestation of Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. 2023 May; 29 (5):324.e1-324.e6 Epub 2023 Jan 20 View PubMed Tun AM, Wang Y, Matin A, Inwards DJ, Habermann TM, Micallef I, Johnston PB, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Tun HW, Cerhan JR, Witzig TE, Nowakowski GS, Ansell SM. Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant. Hemasphere. 2023 Apr; 7 (4):e869 Epub 2023 Apr 04 View PubMed PST-20569626 主页 出版物